Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer

Area of Science:

• Oncology
• Medical Imaging
• Biomarker Discovery

Background:

• Breast cancer is the most common cancer in women, exhibiting diverse progression and treatment responses.
• Current patient management relies on invasive immunohistochemistry of bioptic samples, which may not fully represent the disease.
• Targeting agents for imaging and therapy are being developed based on specific breast cancer subtype biomarkers.

Purpose of the Study:

• To review the development of novel nuclear imaging tracers for breast cancer.
• To highlight tracers in preclinical and clinical studies for guiding treatment decisions.
• To explore imaging's role in whole-body assessment and early treatment response evaluation.

Main Methods:

• Review of preclinical and clinical studies on novel nuclear imaging tracers for breast cancer.
• Analysis of tracer development for targeting specific breast cancer biomarkers.
• Evaluation of imaging techniques for assessing receptor status and disease progression.

Main Results:

• Novel tracers are under development, showing promise for breast cancer management.
• Nuclear imaging offers whole-body information, potentially overcoming limitations of bioptic sampling.
• Imaging can guide treatment selection and evaluate early response, reducing unnecessary therapies.

Conclusions:

• Nuclear imaging tracers represent a promising tool for personalized breast cancer treatment.
• This approach may improve diagnostic accuracy and therapeutic efficacy compared to traditional methods.
• Further development of these tracers is crucial for advancing breast cancer care.